| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/22/2009 | US20090023735 Sulphonamide Derivatives |
| 01/22/2009 | US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections |
| 01/22/2009 | US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections |
| 01/22/2009 | US20090023228 Dual-acting Imidazole antihypertensive agents |
| 01/21/2009 | EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion |
| 01/21/2009 | EP2016070A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016058A1 Inhibitors of c-fms kinase |
| 01/21/2009 | EP2016057A1 C-fms kinase inhibitors |
| 01/21/2009 | EP2016034A2 Mono-nitration of aromatic compounds |
| 01/21/2009 | CN101348487A Preparation of multi-sulfonic functional ion liquid |
| 01/21/2009 | CN101348465A Preparation of imidazophenylurea hydrochloride |
| 01/21/2009 | CN101348448A Preparation of ion liquid having B acid center and L acid center |
| 01/21/2009 | CN101347739A Solid acid catalyst and reaction technique for synthesis of allantoin |
| 01/21/2009 | CN100453533C Acceptor excitant of a class of pancreas hyperglycemia peptide-1, preparation method and usage |
| 01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
| 01/20/2009 | CA2502856C Intermediates for retroviral protease inhibiting compounds |
| 01/20/2009 | CA2295599C Novel heterocyclic analogs of diphenylethylene compounds |
| 01/20/2009 | CA2291417C Corrosion inhibitor compositions |
| 01/20/2009 | CA2289880C A therapeutic agent for intractable vasculitis |
| 01/20/2009 | CA2253901C Process for the preparation of formylimidazoles |
| 01/15/2009 | WO2009009480A2 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 01/15/2009 | WO2009007636A2 Novel cationic surfactant, composition containing same, use thereof as conditioner, and cosmetic treatment method |
| 01/15/2009 | WO2009007399A1 New compounds as hsp90 inhibitors |
| 01/15/2009 | WO2008132142A3 New heterocyclic derivatives useful for the treatment of cns disorders |
| 01/15/2009 | WO2008098657A3 Chemical compounds |
| 01/15/2009 | WO2008089005A3 Renin inhibitors |
| 01/15/2009 | US20090018293 Process for the preparation of a metaloorganic compound comprising at least one imine ligand |
| 01/15/2009 | US20090018180 2-imidazolines |
| 01/15/2009 | US20090018179 Novel crystals and process of making 5-(-methyl)-2-methoxy-benzoic acid |
| 01/15/2009 | US20090018171 Imidazole derivatives |
| 01/15/2009 | US20090018150 5-Ht2b Receptor Antagonists |
| 01/15/2009 | US20090018087 Neuronal disorders such as Alzheimer's disease, Down Syndrome, Parkinson disease, Chorea Huntington, pathogenic psychotic conditions, schizophrenia, impaired food intake, sleep-wakefulness, impaired homeostatic regulation of energy metabolism, impaired autonomic function; alcoholism |
| 01/15/2009 | US20090018058 Vitamin D Receptor Modulators |
| 01/15/2009 | DE112007000484T5 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins |
| 01/15/2009 | DE102007032800A1 Nichtsteroidale Progesteronrezeptor-Modulatoren Non-steroidal progesterone receptor modulators |
| 01/15/2009 | CA2695126A1 Novel crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy- benzoic acid |
| 01/14/2009 | EP2014285A1 NPYY5 antagonists |
| 01/14/2009 | EP2013187A2 Diarylthiohydantoin compounds |
| 01/14/2009 | EP2013186A1 Imidazole derivatives for use as edg-1 antagonists |
| 01/14/2009 | EP1622894B1 Antitumoral antiandrogenic pyrrolidines |
| 01/14/2009 | EP1395567B1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| 01/14/2009 | CN101346350A Method for production of heteroaromatic ring compound having n-rf group |
| 01/14/2009 | CN101343252A Method for separating 2,4-diphenyl oxazole and 2,4-diphenyl imidazole mixture |
| 01/14/2009 | CN101341872A Ion liquid anti-virus activities bactericide, synthesis and application thereof |
| 01/14/2009 | CN100451006C Carboxyl acylamide compound and its preparing method and use |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476727 Conjugates of mycophenolic acid |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection |
| 01/13/2009 | CA2216542C 1,3-dihydro-2h-imidazol-2-one derivatives having pde iv and cytokinin inhibiting activity |
| 01/08/2009 | WO2009005460A1 Small molecule inhibitors of navl.7 sodium channels for the treatment of pain disorders |
| 01/08/2009 | WO2009005135A1 Curing agent for epoxy resin and curing agent composition for epoxy resin |
| 01/08/2009 | WO2009004060A1 Novel triazine compounds for treatment of cancer |
| 01/08/2009 | WO2009004032A1 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests |
| 01/08/2009 | WO2009003868A2 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 01/08/2009 | WO2009003867A1 4-imidazolines and their use as antidepressants |
| 01/08/2009 | US20090012309 Chemical compounds |
| 01/08/2009 | US20090012307 Process for the Preparation of 4-(imidazol-1-yl)benzenesulfonamide Derivatives |
| 01/08/2009 | US20090012306 Cationic Amino Acid Type Lipid |
| 01/08/2009 | US20090012302 Method of isolating a nucleic acid using a material containing an amino group and a carboxyl group and positively charged at a first ph and a solid material for nucleic acid isolation used for the method |
| 01/08/2009 | US20090012300 Process for the Preparation of an (Hetero) Arylamine |
| 01/08/2009 | US20090012141 Composition and Method for Making Oligo-Benzamide Compounds |
| 01/08/2009 | US20090012139 Amino-5-[4-(difluoromethoxy) phenyl]-5-phenylimidazolone compounds for the inhibition of beta-secretase |
| 01/08/2009 | US20090012138 such as 4-naphthalen-1-ylmethyl-4,5-dihydro-1H-imidazole, useful for the treatment of depression, anxiety, bipolar disorder, schizophrenia, Parkinson's disease, Alzheimer's disease, epilepsy, migraine, hypertension, substance abuse, metabolic, cardiovascular and attention deficit disorder |
| 01/08/2009 | US20090012070 Pesticidal heterocycles |
| 01/08/2009 | CA2691704A1 4-imidazolines and their use as antidepressants |
| 01/08/2009 | CA2691573A1 1-(azolin-2-yl)amino-1,2-diphenylethane compounds for combating animal pests |
| 01/08/2009 | CA2691178A1 Novel triazene compounds for the treatment of cancer |
| 01/08/2009 | CA2691082A1 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 01/07/2009 | EP2010522A1 Process for making cytokine inhibiting compounds containing 4- and 5- imidazolyl rings and the intermediates thereof |
| 01/07/2009 | EP2010501A2 Imidazole-based compounds, compositions comprising them and methods of their use |
| 01/07/2009 | EP2010479A1 11 beta-hydroxysteroid dehydrogenase type 1 active compounds |
| 01/07/2009 | EP2010477A2 Poly (ethylene glycol) containing chemically disparate endgroups |
| 01/07/2009 | CN101341131A Imidazoles as gaba-b receptor modulators |
| 01/07/2009 | CN101341130A Imidazole derivatives for the treatment of gastrointestinal disorders |
| 01/07/2009 | CN101341129A Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 01/07/2009 | CN101337939A Alkaline ionic liquid, method for preparing same and applications |
| 01/07/2009 | CN101337938A Method for synthesizing acetate ionic liquid |
| 01/07/2009 | CN100448444C Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors |
| 01/06/2009 | CA2216546C 1,3-dihydro-1-(phenylalkenyl)-2h-imidazol-2-one derivatives having pde iv and cytokine inhibiting activity |
| 01/06/2009 | CA2149770C Detection of hypoxia |
| 01/01/2009 | US20090005580 Compounds, compositions and methods |
| 01/01/2009 | US20090005428 Imidazole Derivatives for the Treatment of Gastrointestinal Disorders |
| 01/01/2009 | US20090005415 1,2-Diarylimidazoles for Use as Cb1 Modulators |
| 01/01/2009 | US20090005410 N-(4-Chloro-2-[1,2,3]triazolo[4,5-b]pyridin-1-yl-phenyl)-4-(1-hydroxy-1-methyl-ethyl)-benzene-sulfonamide sodium salt, used as chemokine receptors antagonists, useful for treating inflammation |
| 12/31/2008 | WO2009001942A1 Method for production of 3-hydroxypropan-1-one compound, method for production of 2-propen-1-one compound, and method for production of isoxazoline compound |
| 12/31/2008 | WO2009001017A2 Marking reagents bearing diazo and nitro functions, methods for the synthesis of such reagents and methods for detecting biological molecules |
| 12/31/2008 | WO2009000753A1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres |
| 12/31/2008 | WO2008135181A3 Insecticidal substituted 2-aminoindanes |
| 12/31/2008 | WO2008132139A3 New heterocyclic derivatives useful for the treatment of cns disorders |
| 12/31/2008 | WO2008115250A3 Fluid storage and purification method and system using ionic liquid in particular di-imidazolium cation |
| 12/31/2008 | EP2009002A1 New process for the manufacture of 1H-imidazo [4,5-c]-quinoline ring systems |
| 12/31/2008 | EP2008318A1 Method for preparing doped organic semiconductor materials and formulation utilized therein |
| 12/31/2008 | EP2007734A1 Enzyme inhibitors |
| 12/31/2008 | EP2007732A2 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 12/31/2008 | EP2007714A2 Orally bioavailable caffeic acid related anticancer drugs |
| 12/31/2008 | EP2007705A1 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use |
| 12/31/2008 | EP1364957B1 Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
| 12/31/2008 | EP1051397B1 Method for preparing an n- (aliphatic or aromatic)carbonyl -2-aminoacetamide compound and a cyclyzed compound |
| 12/31/2008 | CN101336229A 改性的拟赖氨酸化合物 Proposed modification of lysine compound |